Late-Stage C(sp2)–C(sp3) Diversification via Nickel Oxidative Addition Complexes

Added on:
22 Aug, 2023

Nickel catalysis has emerged as a powerful technique for streamlining the access to exceedingly complex organic molecules from simple precursors. However, nickel-catalyzed cross-couplings with advanced synthetic intermediates still remain a considerable challenge. Herein, we describe a technique based on the utilization of nickel oxidative addition complexes (Ni-OAC) of drug-like molecules as a platform to rapidly and reliably generate lead candidates with enhanced C(sp3) fraction. The potential of Ni-OACs to access new chemical space has been assessed in three different C(sp2)–C(sp3) bond-forming events without recourse to specialized ligand backbones. Reactions with Ni-OACs proceed under exceptionally mild conditions and with improved generality when compared to nickel-catalyzed reactions. The development of an automated process for forging C(sp2)–C(sp3) architectures further illustrates the robustness and generality of Ni-OACs, thus offering a new gateway to expedite the design-make-test-analyze (DMTA) cycle in drug discovery

  • Carlota Odena1,3, María Lourdes Linares4, Nahury Castellanos-Blanco1, Ryan T. McGuire1, Jose Manuel Alonso4, Alejandro Diéguez5, Eric Tan5, Jesús Alcázar4, Peter Buijnsters5 Santiago Cañellas4 and Ruben Martin1,2
  • 1Institute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Av. Països Catalans 16, 43007 Tarragona, Spain
  • 2ICREA, Passeig Lluïs Companys 23, 08010 Barcelona, Spain
  • 3Department de Química Analítica i Química Orgànica, Universitat Rovira i Virgili, c/ Marcel·lí Domingo 1, 43007 Tarragona, Spain
  • 4Janssen Research and Development, Janssen-Cilag, S. A. c/ Rio Jarama 75, 45007 Toledo, Spain
  • 5Medicinal Chemistry, Janssen Pharmaceutica, N. V. B-2340 Beerse, Belgium
Read the publication that featured this abstract